Abstract:IDH mutations lead to the inability of IDH to convert isocitrate into α-ketoglutarate (α-KG). Instead, α-KG is reduced into an oncometabolite, D-2-hydroxyglutarate (D-2HG). IDH mutations occur in more than 50% of patients with conventional or dedifferentiated chondrosarcoma. However, the function of these mutations in the pathogenesis of chondrosarcoma is still unclear. In this study, we aimed to establish a mutant IDH1 knockout model in a chondrosarcoma cell line and determine the role of mutant IDH1 in this malignancy. In our study, we employed a human chondrosarcoma cell line, JJ012 which harbors an endogenous IDH1R132G mutation. As a control, we also used an immortalized chondrocyte cell line, C28 which expresses wildtype IDH1 only. IDH1 was knocked out via CRISPR/Cas9 technology. Quantitative analyses of D-2HG were conducted by tandem mass spectrometry. RNA-Seq analysis was performed to identify differentially expressed genes between the mutant IDH1 knockout (KO) cells and the parental cells. RNA-Seq data were validated by real time PCR. Colony-forming ability of KO cells under hypoxia and normoxia conditions was evaluated using soft agar assay. The effect of mutant IDH1 on chondrosarcoma growth was analyzed in murine xenograft models. The expression of HIF1-1α and its targeted genes were examined in cells and tumor tissues by western blot and Immunohistochemistry (IHC). Mutant IDH1 was successfully knocked out in JJ012 cells. Single cell-derived KO clones were then identified and developed. As expected, D-2HG production is almost completely depleted in these KO clones. Using these genetically modified cells, we found that knockout of mutant IDH1 remarkably inhibited colony formation by 40% under normoxia condition compared to the parental control (p<0.05). Intriguingly, we observed that the HIF1-α levels were significantly reduced in the JJ012 KO cells compared with the parental cells. Moreover, RNA-seq data showed a widespread downregulation of HIF1-1α targeted genes such as VEGFA, VEGFC, SLC2A3, EDN1 in response to the knockout (FDR-adjusted p value < 0.01). These data were confirmed by qRT-PCR. The soft-agar colony formation assay further showed a significantly increased colony number and diameter for JJ012 KO cells under hypoxia condition compared with those under normoxia condition (P<0.05). Furthermore, we observed that loss of mutant IDH1 led to a marked attenuation of chondrosarcoma formation in the murine xenograft model. Immunoblotting and IHC revealed that HIF-1α and its targeted genes were dramatically downregulated in the KO cell-derived tumors. We found that mutant IDH1 contributes to tumorigenicity of chondrosarcoma cells, at least partially through the upregulation of HIF1-α. This suggests that targeting HIF1-α signaling pathway is promising for combinatorial regimens with mutant IDH inhibitors for patients with IDH1-mutant chondrosarcoma.

IDH1, a CHOP and C/EBPβ-responsive Gene under ER Stress, Sensitizes Human Melanoma Cells to Hypoxia-Induced Apoptosis.

Effector T Cells under Hypoxia Have an Altered Transcriptome Similar to Tumor-Stressed T Cells Found in Non-Responsive Melanoma Patients

IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in Glioma cells in vitro and in vivo.

IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming in a metabolic enzyme independent manner

IDH1 Arg-132 Mutant Promotes Tumor Formation Through Down-Regulating P53.

IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum Starvation.

Up-regulated Isocitrate Dehydrogenase 1 Suppresses Proliferation, Migration and Invasion in Osteosarcoma: in Vitro and in Vivo

Effect of hypoxia factors gene silencing on ROS production and metabolic status of A375 malignant melanoma cells

The XBP1‒MARCH5‒MFN2 Axis Confers Endoplasmic Reticulum Stress Resistance by Coordinating Mitochondrial Fission and Mitophagy in Melanoma.

Inactivation/deficiency of DHODH Induces Cell Cycle Arrest and Programed Cell Death in Melanoma

Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma

Chondrosarcoma-derived Mutation in IDH1 Promotes Tumorigenesis by Inducing HIF-1α

IDH1 R132H Mutation Regulates Glioma Chemosensitivity Through Nrf2 Pathway.

COP1/DET1/ETS Axis Regulates ERK Transcriptome and Sensitivity to MAPK Inhibitors

[Role of dysregulation of Bim in resistance of melanoma cells to endoplasmic reticulum stress-induced apoptosis].

Determination of Hypoxia Signature to Predict Prognosis and the Tumor Immune Microenvironment in Melanoma

IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced

Abstract 1029: Receptor-interacting Protein Kinase 1 Regulates Survival of Human Melanoma Cells Upon Endoplasmic Reticulum Stress Through Autophagy

<i>IDH1</i> mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis

Mutation of Isocitrate Dehydrogenase 1 Induces Glioma Cell Proliferation Via Nuclear Factor-Κb Activation in a Hypoxia-Inducible Factor 1-Α Dependent Manner.